Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Search Results to Paul A Bunn

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following items that are connected to Bunn, Paul

Item TypeName
Academic Article Evaluation of response to chemotherapy with fiberoptic bronchoscopy in non-small cell lung cancer.
Academic Article Effects of neuropeptide analogues on calcium flux and proliferation in lung cancer cell lines.
Academic Article New treatment agents for advanced small cell and non-small cell lung cancer.
Academic Article A phase I study of carboplatin and paclitaxel in non-small cell lung cancer: a University of Colorado Cancer Center study.
Academic Article Secondary screening system for preclinical testing of human lung cancer therapies.
Academic Article The treatment of non-small cell lung cancer: current perspectives and controversies, future directions.
Academic Article Controversies in the nonsurgical treatment of stage III non-small cell lung cancer.
Academic Article Elevated DT-diaphorase activity and messenger RNA content in human non-small cell lung carcinoma: relationship to the response of lung tumor xenografts to mitomycin Cl.
Academic Article Clinical experiences with carboplatin (paraplatin) in lung cancer.
Academic Article Combination paclitaxel and platinum in the treatment of lung cancer: US experience.
Academic Article Future directions in therapeutic approaches for small cell lung cancer.
Academic Article The emerging role of gemcitabine in lung cancer: part I.
Academic Article The North American experience with paclitaxel combined with cisplatin or carboplatin in lung cancer.
Academic Article Induction paclitaxel/carboplatin in early stage non-small cell lung cancer. Bimodality Lung Oncology Team.
Academic Article A phase I study of daily carboplatin and simultaneous accelerated, hyperfractionated chest irradiation in patients with regionally inoperable non-small cell lung cancer.
Academic Article Is it time to reevaluate our approach to the treatment of brain metastases in patients with non-small cell lung cancer?
Academic Article Daily low-dose cisplatin plus concurrent high-dose thoracic irradiation in locally advanced unresectable non-small-cell lung cancer: results of a phase II Southwest Oncology Group study.
Academic Article Induction chemotherapy before surgery for early-stage lung cancer: A novel approach. Bimodality Lung Oncology Team.
Academic Article New therapeutic strategies for lung cancer: biology and molecular biology come of age.
Academic Article New combinations in the treatment of lung cancer: a time for optimism.
Academic Article HER-2/neu as a therapeutic target in non-small cell lung cancer, prostate cancer, and ovarian cancer.
Academic Article Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non--small-cell lung cancer: a Southwest Oncology Group trial.
Academic Article ZD1839, a selective epidermal growth factor receptor tyrosine kinase inhibitor, alone and in combination with radiation and chemotherapy as a new therapeutic strategy in non-small cell lung cancer.
Academic Article Exisulind in combination with docetaxel inhibits growth and metastasis of human lung cancer and prolongs survival in athymic nude rats with orthotopic lung tumors.
Academic Article Evaluation of HER-2/neu gene amplification and protein expression in non-small cell lung carcinomas.
Academic Article Bradykinin antagonist dimer, CU201, inhibits the growth of human lung cancer cell lines in vitro and in vivo and produces synergistic growth inhibition in combination with other antitumor agents.
Academic Article Pemetrexed as a single agent in the therapy of advanced lung cancer.
Academic Article Incorporation of pemetrexed (Alimta) into the treatment of non-small cell lung cancer (thoracic tumors).
Academic Article HER2/neu expression in malignant lung tumors.
Academic Article Defining the role of paclitaxel in lung cancer: summary of recent studies and implications for future directions.
Academic Article Chemotherapy for advanced non-small-cell lung cancer: who, what, when, why?
Academic Article An update on North American randomized studies in non-small cell lung cancer.
Academic Article Triplet chemotherapy combinations with new agents: is there a rationale?
Academic Article Chemotherapy for elderly patients with advanced non-small-cell lung cancer.
Academic Article Taxanes in the treatment of advanced (stage III and IV) non-small cell lung cancer (NSCLC): recent developments.
Academic Article Effects of recombinant neutral endopeptidase (EC 3.4.24.11) on the growth of lung cancer cell lines in vitro and in vivo.
Academic Article Understanding the mechanisms of action of EGFR inhibitors in NSCLC: what we know and what we do not know.
Academic Article Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis.
Academic Article The potential role of proteasome inhibitors in the treatment of lung cancer.
Academic Article Phase II study of pemetrexed-gemcitabine combination in patients with advanced-stage non-small cell lung cancer.
Academic Article Targeted therapies for non-small-cell lung cancer: biology, rationale, and preclinical results from a radiation oncology perspective.
Academic Article Platinums in lung cancer: sufficient or necessary?
Academic Article Early-stage non-small-cell lung cancer: current perspectives in combined-modality therapy.
Academic Article Triplet chemotherapy with gemcitabine, a platinum, and a third agent in the treatment of advanced non-small cell lung cancer.
Academic Article Multicenter phase I/II study of cetuximab with paclitaxel and carboplatin in untreated patients with stage IV non-small-cell lung cancer.
Academic Article Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer.
Academic Article Increased epidermal growth factor receptor gene copy number detected by fluorescence in situ hybridization associates with increased sensitivity to gefitinib in patients with bronchioloalveolar carcinoma subtypes: a Southwest Oncology Group Study.
Academic Article HER3 genomic gain and sensitivity to gefitinib in advanced non-small-cell lung cancer patients.
Academic Article Biological markers for non-small cell lung cancer patient selection for epidermal growth factor receptor tyrosine kinase inhibitor therapy.
Academic Article Baseline gene expression predicts sensitivity to gefitinib in non-small cell lung cancer cell lines.
Academic Article Elderly patients benefit from second-line cytotoxic chemotherapy: a subset analysis of a randomized phase III trial of pemetrexed compared with docetaxel in patients with previously treated advanced non-small-cell lung cancer.
Academic Article Epidermal growth factor receptor messenger RNA expression, gene dosage, and gefitinib sensitivity in non-small cell lung cancer.
Academic Article Selecting lung cancer patients for treatment with epidermal growth factor receptor tyrosine kinase inhibitors by immunohistochemistry and fluorescence in situ hybridization--why, when, and how?
Academic Article Can a single pill replace doublet chemotherapy in first-line therapy of advanced non-small cell lung cancer?
Academic Article From radiotherapy to Targeted therapy: 20 years in the management of non-small-cell lung cancer.
Academic Article Mass spectrometry to classify non-small-cell lung cancer patients for clinical outcome after treatment with epidermal growth factor receptor tyrosine kinase inhibitors: a multicohort cross-institutional study.
Academic Article Epidermal growth factor receptor immunohistochemistry: comparison of antibodies and cutoff points to predict benefit from gefitinib in a phase 3 placebo-controlled study in advanced nonsmall-cell lung cancer.
Academic Article Systemic treatment for advanced (stage IIIb/IV) non-small cell lung cancer: more treatment options; more things to consider. Introduction.
Academic Article Fibroblast growth factor (FGF) and FGF receptor-mediated autocrine signaling in non-small-cell lung cancer cells.
Academic Article Increased EGFR gene copy number detected by fluorescent in situ hybridization predicts outcome in non-small-cell lung cancer patients treated with cetuximab and chemotherapy.
Academic Article Fluorescence in situ hybridization subgroup analysis of TRIBUTE, a phase III trial of erlotinib plus carboplatin and paclitaxel in non-small cell lung cancer.
Academic Article EGFR and HER2 genomic gain in recurrent non-small cell lung cancer after surgery: impact on outcome to treatment with gefitinib and association with EGFR and KRAS mutations in a Japanese cohort.
Academic Article EGFR testing in lung cancer is ready for prime time.
Academic Article Novel therapies for non-small-cell lung cancer: a 2008 update.
Academic Article New strategies to overcome limitations of reversible EGFR tyrosine kinase inhibitor therapy in non-small cell lung cancer.
Academic Article Optimal therapy for elderly patients with early stage non-small cell lung cancer.
Academic Article Insulin-like growth factor receptor 1 (IGF1R) gene copy number is associated with survival in operable non-small-cell lung cancer: a comparison between IGF1R fluorescent in situ hybridization, protein expression, and mRNA expression.
Academic Article Synergistic effects of new chemopreventive agents and conventional cytotoxic agents against human lung cancer cell lines.
Academic Article The expanding role of cisplatin in the treatment of non-small-cell lung cancer.
Academic Article ZEB1-responsive genes in non-small cell lung cancer.
Academic Article Adjuvant and neoadjuvant chemotherapy for non-small cell lung cancer: a time for reassessment?
Academic Article A phase I/II trial of paclitaxel, carboplatin, and gemcitabine in untreated patients with advanced non-small cell lung cancer.
Academic Article Epidermal growth factor receptor family in lung cancer and premalignancy.
Academic Article Preclinical and clinical studies of docetaxel and exisulind in the treatment of human lung cancer.
Academic Article Randomized phase II trial of erlotinib with and without entinostat in patients with advanced non-small-cell lung cancer who progressed on prior chemotherapy.
Academic Article Tankyrase and the canonical Wnt pathway protect lung cancer cells from EGFR inhibition.
Academic Article Non-invasive breath analysis of pulmonary nodules.
Academic Article Symptomatic reduction in free testosterone levels secondary to crizotinib use in male cancer patients.
Academic Article Non-small-cell lung cancer. Major cause of late mortality in patients with small cell lung cancer.
Academic Article Irinotecan and platinums in the treatment of non small-cell lung cancer.
Academic Article Combinations of three chemotherapeutic agents and two chemotherapeutic agents plus a targeted biologic agent in the treatment of advanced non small-cell lung cancer.
Academic Article Future directions in clinical research for lung cancer.
Academic Article Novel agents in the treatment of lung cancer: conference summary statement.
Academic Article European School of Oncology. First Euro-American Forum on Lung Cancer Treatment.
Academic Article Neutral endopeptidase: variable expression in human lung, inactivation in lung cancer, and modulation of peptide-induced calcium flux.
Academic Article New investigative regimens and cytotoxic agents in thoracic cancers: gemcitabine and pemetrexed.
Academic Article Carboxypeptidase M. Variable expression in normal human lung and inactivation in lung cancer.
Academic Article The effects of cetuximab alone and in combination with radiation and/or chemotherapy in lung cancer.
Academic Article New chemotherapeutic agents prolong survival and improve quality of life in non-small cell lung cancer: a review of the literature and future directions.
Academic Article A phase I trial of paclitaxel plus carboplatin in untreated patients with advanced non-small cell lung cancer.
Academic Article Gemcitabine plus docetaxel for advanced or metastatic non-small cell lung cancer: similar survival to cisplatin plus vinorelbine and less toxicity.
Academic Article Restoring E-cadherin expression increases sensitivity to epidermal growth factor receptor inhibitors in lung cancer cell lines.
Academic Article Triplet combination chemotherapy and targeted therapy regimens.
Academic Article Maximum tolerated dose for low-dose continuous infusion cisplatin.
Academic Article Molecular predictors of outcome with gefitinib in a phase III placebo-controlled study in advanced non-small-cell lung cancer.
Academic Article Epidermal growth factor receptor gene copy number and protein level are not associated with outcome of non-small-cell lung cancer patients treated with chemotherapy.
Academic Article Growth factors in lung cancer: possible etiologic role and clinical target.
Academic Article [State-of-the art treatment of locally advanced and metastatic non-small cell lung cancer].
Academic Article Exisulind-induced apoptosis in a non-small cell lung cancer orthotopic lung tumor model augments docetaxel treatment and contributes to increased survival.
Academic Article Ongoing and future trials of biologic therapies in lung cancer.
Academic Article Improved tumor imaging with radiolabeled monoclonal antibodies by plasma clearance of unbound antibody with anti-antibody column.
Academic Article Targeting the epidermal growth factor receptor in non-small cell lung cancer.
Academic Article Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy.
Academic Article Antitumor activity of ZD6126, a novel vascular-targeting agent, is enhanced when combined with ZD1839, an epidermal growth factor receptor tyrosine kinase inhibitor, and potentiates the effects of radiation in a human non-small cell lung cancer xenograft model.
Academic Article Increased HER2 gene copy number is associated with response to gefitinib therapy in epidermal growth factor receptor-positive non-small-cell lung cancer patients.
Academic Article Epithelial to mesenchymal transition predicts gefitinib resistance in cell lines of head and neck squamous cell carcinoma and non-small cell lung carcinoma.
Academic Article Single-institution experience with pemetrexed and bevacizumab as salvage therapy in advanced non-small-cell lung cancer.
Academic Article Can acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors be overcome by different small-molecule tyrosine kinase inhibitors?
Academic Article Epidermal growth factor receptor inhibitors in lung cancer: smaller or larger molecules, selected or unselected populations?
Academic Article Adjuvant chemotherapy for resected non-small-cell lung cancer.
Academic Article Insulin-like growth factor receptor 1 (IGFR-1) is significantly associated with longer survival in non-small-cell lung cancer patients treated with gefitinib.
Academic Article Summary statement: novel agents in the treatment of lung cancer: advances in epidermal growth factor receptor-targeted agents.
Academic Article First-generation epidermal growth factor receptor inhibitors in non-small cell lung cancer: clinical impact of the epidermal growth factor receptor fluorescence in situ hybridization assay.
Academic Article Antitumor activity of the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor gefitinib (ZD1839, Iressa) in non-small cell lung cancer cell lines correlates with gene copy number and EGFR mutations but not EGFR protein levels.
Academic Article Combination of EGFR gene copy number and protein expression predicts outcome for advanced non-small-cell lung cancer patients treated with gefitinib.
Academic Article The impact of induction chemotherapy on the outcome of second-line therapy with pemetrexed or docetaxel in patients with advanced non-small-cell lung cancer.
Academic Article Adjuvant chemotherapy for non-small cell lung cancer.
Academic Article Docetaxel and exisulind in previously treated non-small cell lung cancer (NSCLC) patients: a multicenter, phase II clinical trial.
Academic Article Surgery with or without preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancer: Southwest Oncology Group Trial S9900, an intergroup, randomized, phase III trial.
Academic Article Systemic treatment for advanced (stage IIIb/IV) non-small cell lung cancer: more treatment options; more things to consider. Conclusion.
Academic Article EGFR regulation by microRNA in lung cancer: correlation with clinical response and survival to gefitinib and EGFR expression in cell lines.
Academic Article Review of therapeutic trials of carboplatin in lung cancer.
Academic Article The tissue is the issue: personalized medicine for non-small cell lung cancer.
Academic Article ErbB-3 expression is associated with E-cadherin and their coexpression restores response to gefitinib in non-small-cell lung cancer (NSCLC).
Academic Article Early-stage NSCLC: the role of radiotherapy and systemic therapy.
Academic Article MAGE A3 antigen-specific cancer immunotherapeutic.
Academic Article Genetic testing for lung cancer: reflex versus clinical selection.
Academic Article A randomized, phase II, biomarker-selected study comparing erlotinib to erlotinib intercalated with chemotherapy in first-line therapy for advanced non-small-cell lung cancer.
Academic Article Oncogene status predicts patterns of metastatic spread in treatment-naive nonsmall cell lung cancer.
Academic Article Biologically targeted therapies plus chemotherapy plus radiotherapy in stage III non-small-cell lung cancer: a case of the Icarus syndrome?
Academic Article Local ablative therapy of oligoprogressive disease prolongs disease control by tyrosine kinase inhibitors in oncogene-addicted non-small-cell lung cancer.
Academic Article Lung cancer in 2013: state of the art therapy for metastatic disease.
Academic Article Markedly different antibody responses to immunized small cell and non-small cell lung cancer cells.
Concept Carcinoma, Non-Small-Cell Lung
Academic Article Resistance to ROS1 inhibition mediated by EGFR pathway activation in non-small cell lung cancer.
Academic Article Effective crizotinib schedule for brain metastases in ALK rearrangement metastatic non-small-cell lung cancer.
Academic Article Recent clinical advances in lung cancer management.
Academic Article Is there clinical value to prognostic signatures in early-stage NSCLC?
Academic Article FGFR1 mRNA and protein expression, not gene copy number, predict FGFR TKI sensitivity across all lung cancer histologies.
Academic Article "Companion diagnostics": has their time come and gone?
Academic Article Reply to A. Braillon.
Academic Article Phase II trial of stereotactic body radiation therapy combined with erlotinib for patients with limited but progressive metastatic non-small-cell lung cancer.
Academic Article Molecularly targeted therapies in non-small-cell lung cancer annual update 2014.
Academic Article Personalized one-two punches for lung cancer.
Academic Article Improving the Care of Patients With Stage IB Non-Small-Cell Lung Cancer: Role of Prognostic Signatures and Use of Cell Cycle Progression Biomarkers.
Academic Article Molecular Testing for Treatment of Metastatic Non-Small Cell Lung Cancer: How to Implement Evidence-Based Recommendations.
Academic Article Adjuvant TKIs in NSCLC: what can we learn from RADIANT?
Academic Article Neoadjuvant combination chemotherapy for unresectable stage III non-small cell lung cancer.
Academic Article Malignant pleural disease is highly associated with subsequent peritoneal metastasis in patients with stage IV non-small cell lung cancer independent of oncogene status.
Academic Article The International Association for the Study of Lung Cancer Consensus Statement on Optimizing Management of EGFR Mutation-Positive Non-Small Cell Lung Cancer: Status in 2016.
Academic Article Clinicopathologic Features of Advanced Squamous NSCLC.
Academic Article New and emerging targeted treatments in advanced non-small-cell lung cancer.
Academic Article KIR 2D (L1, L3, L4, S4) and KIR 3DL1 protein expression in non-small cell lung cancer.
Academic Article AZ1366: An Inhibitor of Tankyrase and the Canonical Wnt Pathway that Limits the Persistence of Non-Small Cell Lung Cancer Cells Following EGFR Inhibition.
Academic Article The role of irinotecan combined with Cisplatin or Carboplatin in the treatment of advanced non-small-cell lung cancer.
Academic Article Meta-analysis examining impact of age on overall survival with pemetrexed for the treatment of advanced non-squamous non-small cell lung cancer.
Academic Article Current and Emergent Therapy Options for Advanced Squamous Cell Lung Cancer.
Academic Article Long-term safety and survival with gefitinib in select patients with advanced non-small cell lung cancer: Results from the US IRESSA Clinical Access Program (ICAP).
Academic Article Resistance Mechanisms to Targeted Therapies in ROS1+ and ALK+ Non-small Cell Lung Cancer.
Academic Article The combination of anti-KIR monoclonal antibodies with anti-PD-1/PD-L1 monoclonal antibodies could be a critical breakthrough in overcoming tumor immune escape in NSCLC.
Academic Article Predictive biomarkers for response to EGFR-directed monoclonal antibodies for advanced squamous cell lung cancer.
Academic Article The Incidence of Brain Metastases in Stage IV ROS1-Rearranged Non-Small Cell Lung Cancer and Rate of Central Nervous System Progression on Crizotinib.
Academic Article Systemic Therapy for Elderly Patients With Advanced Non-Small-Cell Lung Cancers.
Academic Article HER2 exon 20 insertions in non-small-cell lung cancer are sensitive to the irreversible pan-HER receptor tyrosine kinase inhibitor pyrotinib.
Academic Article Natural History and Factors Associated with Overall Survival in Stage IV ALK-Rearranged Non-Small Cell Lung Cancer.
Academic Article Clinicopathologic Characteristics, Treatment Outcomes, and Acquired Resistance Patterns of Atypical EGFR Mutations and HER2 Alterations in Stage IV Non-Small-Cell Lung Cancer.
Academic Article Round Robin Evaluation of MET Protein Expression in Lung Adenocarcinomas Improves Interobserver Concordance.
Academic Article Cecal Volvulus as a Rare Complication of Osimertinib Dosed at 160 mg in Patients With EGFR-Mutant Non-small Cell Lung Cancer.
Academic Article Optimal Therapy for Advanced Non-Small Cell Lung Cancer Without Driver Alterations.
Academic Article Adjuvant Osimertinib in EGFR-Mutant Early-Stage NSCLC: Does HRQoL Influence Decisions?
Academic Article Analysis of Cancer Survival Associated With Immune Checkpoint Inhibitors After Statistical Adjustment: A Systematic Review and Meta-analyses.
Academic Article Surgical results of the Lung Cancer Mutation Consortium 3 trial: A phase II multicenter single-arm study to investigate the efficacy and safety of atezolizumab as neoadjuvant therapy in patients with stages IB-select IIIB resectable non-small cell lung cancer.
Academic Article Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial.
Academic Article CNS Downstaging: An Emerging Treatment Paradigm for Extensive Brain Metastases in Oncogene-Addicted Lung Cancer.
Academic Article Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non-Small-Cell Lung Cancer Previously Treated With Chemotherapy.
Academic Article International Association for the Study of Lung Cancer Study of Reproducibility in Assessment of Pathologic Response in Resected Lung Cancers After Neoadjuvant Therapy.
Academic Article Author Correction: Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial.

Search Criteria
  • Carcinoma Non Small Cell Lung

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)